Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer’s Disease and Normal Brain

被引:0
作者
Jieun Jeong
Young Jin Jeong
Kyung Won Park
Do-Young Kang
机构
[1] Dong-A University College of Medicine,Department of Nuclear Medicine, Dong
[2] Dong-A University,A University Medical Center
[3] Dong-A University College of Medicine,Institute of Convergence Bio
来源
Nuclear Medicine and Molecular Imaging | 2019年 / 53卷
关键词
Alzheimer’s disease; F-18 florapronol; Dual time; F-18 FDG;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:328 / 333
页数:5
相关论文
共 46 条
[1]  
Jack CR(2013)Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 207-216
[2]  
Knopman DS(2016)A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers Neurology 87 539-547
[3]  
Jagust WJ(2018)Validation of noninvasive tracer kinetic analysis of 18F-florbetaben PET using a dual–time-window acquisition protocol J Nucl Med 59 1104-1110
[4]  
Petersen RC(2017)Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state Clin Nucl Med 42 e80-e87
[5]  
Weiner MW(2008)Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system Cereb Cortex 19 375-382
[6]  
Aisen PS(1981)Usefulness of dual-point amyloid PET scans in appropriate use criteria: a multicenter study Fed Proc 40 2311-2316
[7]  
Jack CR(2018)Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies JAlzheimer’s Dis 2018 1-15
[8]  
Bennett DA(2019)Evaluation of early-phase 18F-florbetaben PET acquisition in clinical routine cases PLoS One 14 e0211000-86
[9]  
Blennow K(2017)undefined NeuroImage: Clinical 14 77-undefined
[10]  
Carrillo MC(undefined)undefined undefined undefined undefined-undefined